Streetbeat News

Products Services

AAPL

GOOG

Apple has reportedly hired dozens of AI experts from Google, establishing a new AI research lab in Zurich, according to Financial Times. This move signifies Apple's aggressive expansion into AI, potentially enhancing its competitive edge in technology and innovation.

Portfolio Pulse from Charles Gross

April 30, 2024 | 9:22 am

XTNT

Xtant Medical has announced the full commercial launch of two amniotic membrane allografts, SimpliGraft and SimpliMax, aimed at treating chronic and acute wounds. This development could potentially enhance Xtant Medical's product portfolio and market presence in the medical allografts sector.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 9:09 am

AMBA

Neusoft Reach and Ambarella have entered into a strategic partnership to accelerate developments in autonomous driving and intelligent automotive technology. This collaboration aims to leverage both companies' strengths to innovate in the rapidly evolving automotive sector.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 9:04 am

BMY

Scenic Biotech has entered into a research collaboration with Bristol Myers Squibb (BMY), granting BMY access to Scenic's Cell-Seq technology. The collaboration aims to explore genetic interactions in cellular pathways. Scenic will receive an upfront payment and may receive more based on achieving certain milestones.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 9:03 am

EGIO

Edgio, a global leader in streaming media technology, has been selected by Tabletop Tactics to manage their end-to-end video workflows, content delivery, and reporting analytics in a single integrated solution. This partnership aims to deliver premium video content globally.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:20 am

TONUSD

Toncoin (TON), associated with Telegram, has surged in value, reaching the top 10 in market capitalization due to its integration with Telegram and potential issuance of Tether tokens within the app. This rise is supported by Telegram's large user base and recent developments, including AI collaborations and the prospect of global cryptocurrency ETF approvals.

Portfolio Pulse from Benzinga Neuro

April 30, 2024 | 8:18 am

NTES

NetEase Cloud Music has entered into an agreement with JYP Entertainment to expand its K-Pop music portfolio for Chinese audiences. The partnership aims to leverage both companies' strengths to promote JYP Entertainment's K-Pop artists and explore new commercial opportunities.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:18 am

MESO

Mesoblast is planning to resubmit its Biologics License Application (BLA) aiming for an accelerated FDA approval following positive interactions during Q3. This move could significantly impact the company's future, signaling potential growth and advancements in its pipeline.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 8:14 am

AMGN

SDZNY

Sandoz and Amgen have settled all patent litigation concerning Sandoz's denosumab biosimilars in the US, paving the way for the launch of Jubbonti and Wyost on or before May 31, 2025. These are the first FDA-approved biosimilars interchangeable with Prolia and Xgeva, expected to enhance Sandoz's biosimilar portfolio and growth strategy.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 7:56 am

TSLA

Elon Musk's recent visit to China has been highlighted as a significant move for Tesla, showcasing Musk's seriousness and gaining investor confidence. The visit, which included a meeting with China's Li Qiang, signals strong government endorsement in China, a crucial market for Tesla. This comes as Tesla recently met China's data security requirements for its vehicles, a step forward for deploying its full self-driving software in China. Tesla's stock spiked over 15% following these developments, indicating a positive market response.

Portfolio Pulse from Benzinga Neuro

April 30, 2024 | 7:42 am